)
Covaxin phase-3 trial will begin as second trial has successful results
The Indian vaccine against COVID-19 Covaxin is drawing some global attention. ICMR shares Covaxin Phase-2 trial results in which they mention that 'data generated within India underlines impressive safety'.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)